Additional PET/CT in week 5–6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?

This publication has 48 references indexed in Scilit:

• Induction and Concurrent Chemotherapy With High-Dose Thoracic Conformal Radiation Therapy in Unresectable Stage IIIA and IIIB Non–Small-Cell Lung Cancer: A Dose-Escalation Phase I Trial
  Journal of Clinical Oncology, 2004
• Improved local control with higher doses of radiation in large-volume stage III non–small-cell lung cancer
  International Journal of Radiation Oncology*Biology*Physics, 2004
• Molecular targeting in radiotherapy of lung cancer
  Lung Cancer, 2004
• Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer
  Lung Cancer, 2004
• High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Dose and fractionation concepts in the primary radiotherapy of non-small cell lung cancer
  Lung Cancer, 2001
• Dose Escalation in Non–Small-Cell Lung Cancer Using Three-Dimensional Conformal Radiation Therapy: Update of a Phase I Trial
  Journal of Clinical Oncology, 2001
• Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial
  Radiotherapy and Oncology, 1999
• Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
  BMJ, 1995